ICOS and neoplasm: To summarize, in cutaneous T-cell lymphomas, the overexpression of ICOS by malignant T cells and Treg cells suggests that depletion of ICOS-expressing cells could both directly reduce the tumor cell burden and activate the antitumor immune responses by killing Tregs.